Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Article activity feed
-
Julio Vega
Review 1: "Astodrimer sodium, dendrimer antiviral, inhibits replication of SARS-CoV-2 in vitro"
-
Julio Vega
Review of "Astodrimer sodium, dendrimer antiviral, inhibits replication of SARS-CoV-2 in vitro"
Reviewers: Julio Vega (Amcyte Pharma) | 📘📘📘📘📘
-
-
-
-
SciScore for 10.1101/2020.08.20.260190: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Virus stock was generated at 360Biolabs (Melbourne, Australia) by two passages in Vero cells in virus growth media, which comprised Minimal Essential Medium (MEM) without L-glutamine supplemented with 1% (w/v) L-glutamine, 1.0 μg/mL of L-(tosylamido-2-phenyl) Verosuggested: NoneVirus and compound mixture were added to Vero E6 cell monolayers in 96-well plates and incubated at 37°C in 5% CO2 for 4 days. Vero E6suggested: NoneResults from …
SciScore for 10.1101/2020.08.20.260190: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Virus stock was generated at 360Biolabs (Melbourne, Australia) by two passages in Vero cells in virus growth media, which comprised Minimal Essential Medium (MEM) without L-glutamine supplemented with 1% (w/v) L-glutamine, 1.0 μg/mL of L-(tosylamido-2-phenyl) Verosuggested: NoneVirus and compound mixture were added to Vero E6 cell monolayers in 96-well plates and incubated at 37°C in 5% CO2 for 4 days. Vero E6suggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-